Inside the research

Humana Inc.

HUM Research profile · latest available data

Price overview

$397.93

▲ +17.61 (+4.6%)

52w hi$409.80
52w lo$162.46
Vol1.94M
As of25 Sep 2026

The Verdict

Buy

Our score +0.76

Short+1.05
Medium+0.68
Long+0.31

computed 2026-09-27

Key fundamentals

Humana Inc.

Healthcare · Healthcare Plans

Market cap$47.78B
Enterprise value$38.72B
Trailing P/E37.61x
Forward P/E23.98x
EV / EBITDA10.77x
P / S (ttm)0.33x
Profit margin0.9%
Return on equity6.9%
Revenue growth+26.2%
Earnings growth+27.1%
Debt / equity76.48

Layer Breakdown

LayerRawContribution
Fundamental+0.22
Sector+0.08
Technical+0.21
Earnings+0.00
Sentiment+0.91

macro × 1.00 · 2026-09-27

Business overview

Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and ancillary insurance comprising dental, vision, life and disability; and administrative services to arrange health care services for active-duty and retired military personnel and dependents, as well as pharmacy benefit managers. Its CenterWell segment operates full-service, value-based senior focused primary care centers under the Conviva Senior Primary Care and CenterWell Senior Primary Care brands; a management services organization; CenterWell Home Health, a home health provider; and OneHome, which manages post-acute patient needs, as well as provides pharmacy and hospice solutions. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

United States · www.humana.com

Risk Metrics

Beta vs SPX0.51
Corr SPX0.17
Annual vol46.9%
Annual ret+23.6%
Sharpe0.50
Max DD-48.8%

Window: 504 trading days (504 obs)

Analyst Coverage

Mean PT$243.71
High / Low$333.00 / $146.00
Median$252.50
Analysts24
Strong Buy2
Buy6
Hold16
Sell2
Strong Sell0

Recent rating actions

2026-05-01TD Cowen→ Hold
2026-05-01JP Morgan→ Neutral
2026-04-30UBS→ Neutral
2026-04-30Truist Securities→ Hold
2026-04-30RBC Capital→ Sector Perform
2026-04-30Guggenheim→ Buy

Officers & Board

DirectorBrad Smith since 2022
DirectorDavid Feinberg since 2022
DirectorMarcy Klevorn since 2021
DirectorJorge Mesquita since 2021
DirectorRaquel C. Bono since 2020
DirectorWayne A.I. Frederick since 2020
DirectorJohn Garratt since 2020
DirectorKaren Katz since 2019
DirectorKurt Hilzinger since 2014
DirectorBruce Broussard since 2011
DirectorWilliam McDonald since 2007
DirectorJames O'Brien since 2006
DirectorFrank D'Amelio since 2003
DirectorDavid A. Jones, Jr. since 1993
FounderWendell Cherry current

Material Events

DateEvent8-K
2026-07-29Officer / Director Change, Exhibitsread
2026-07-29Earnings Release, Reg FD Disclosure…read
2026-06-01Reg FD Disclosureread
2026-05-19Material Agreement, Material Obligation…read
2026-04-29Earnings Release, Reg FD Disclosure…read
2026-04-20Shareholder Voteread
2026-04-10Officer / Director Changeread
2026-03-09Material Agreement, Material Obligation…read
2026-03-02Reg FD Disclosureread
2026-02-11Earnings Release, Reg FD Disclosure…read
2025-12-16Officer / Director Change, Reg FD Disclosure…read
2025-12-01Reg FD Disclosureread

Insider Trades

DateInsiderRoleActionSharesValue
2026-08-01Smith Paul JohnGrant544—
2026-08-01Crawford Frederick JohnGrant544—
2026-05-01Mellet CelesteChief Financial OfficerGrant15.39K—
2026-05-01Mehta JapanChief Information OfficerGrant9.45K—
2026-05-01Dintenfass DavidPresident, Enterprise GroGrant11.27K—
2026-05-01Rechtin James A.President & CEOGrant35.63K—
2026-05-01O'Hara Michelle A.Chief Human Resources OffGrant10.48K—
2026-05-01Field Robert StuartGrant852—
2026-05-01Ventura Joseph CChief Legal OfficerGrant10.32K—

Flow & Concentration

Insider 180d net$0
Insider buys / sells0 / 0
Insider biasNeutral
13F holders9
Top-5 share98.0%
HHI3,187 (concentrated)

Top Holders

HolderValueShares
State Street Corp$2.17B5.46M
Fidelity / FMR LLC$1.16B2.91M
Citadel Advisors$852.64M2.15M
Millennium Management$185.66M467.40K
Capital Research / Capital World$176.62M444.65K
AQR Capital Management$86.81M222.41K
Bridgewater Associates$3.64M9.15K
Renaissance Technologies$3.42M8.60K
T. Rowe Price Group$320.49K806.82K

As of 2026-06-30

Dividends

Yield (TTM)0.44%
$ / share (TTM)$1.77
5y CAGR+7.2%

Annual dividend per share

2021$2.80
2022$3.15
2023$3.54
2024$3.54
2025$3.54
2026$0.89

SEC Filings

DateFormDoc
2026-08-044view
2026-08-044view
2026-07-298-Kview
2026-07-293view
2026-07-2910-Qview
2026-07-298-Kview
2026-07-293view
2026-07-024view
2026-06-2411-Kview
2026-06-2411-Kview
2026-06-018-Kview
2026-05-198-Kview
2026-05-054view
2026-05-054view
2026-05-054view

The Long Run

FY 2009–2025 · 17 years

LineLatestCAGRTrend
Revenue$117.76B+9.2%
Operating income$4.01B+7.0%
Net income$2.49B+7.1%
Cash from ops$2.97B+5.7%

Indices

S&P 500

Recent Sessions

DateOpenHighLowCloseVol
Sep 25$389.70$413.57$386.71$397.931.94M
Sep 24$374.54$382.30$372.08$380.32899.00K
Sep 23$370.00$377.68$369.13$374.78798.60K
Sep 22$378.42$379.91$370.00$372.00858.10K
Sep 21$386.20$386.67$374.35$378.58925.80K

Understand the score. Research layers are inputs to a model, and the available data has limits.

Read the methodology →